X0609 4 2026-10-21 0001877184 KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS 0001877198 Umberger Traci S false 3933 LAKE WASHINGTON BLVD NE, SUITE 200 KIRKLAND WA 98033 true true false false See Remarks true Common Shares 2026-10-21 4 M false 100000 17.00 A 295825 D Common Shares 2026-10-21 4 S false 96404 27.1493 D 199421 D Common Shares 2026-10-21 4 S false 3596 28.0915 D 195825 D Options 17.00 2026-10-21 4 M false 100000 0 D 2035-03-06 Common Stock 100000 441000 D This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.8050 to $27.7927. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.8200 to $28.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Includes 395,919 fully vested options as of the filing date, with the remaining 45,081 options vesting in equal monthly installments through March 6, 2027. General Counsel and Chief Adminstrative Officer /s/ Traci S. Umberger 2026-10-22